Travere Therapeutics, Inc.

Historical 13F Holders

Symbol
TVTX
CUSIP
89422G107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 235 98.0 M $1.77 B
2024 Q4 212 95.1 M $1.66 B
2024 Q3 190 83.4 M $1.17 B
2024 Q2 182 92.3 M $771 M
2024 Q1 188 95.2 M $734 M
2023 Q4 181 91.6 M $823 M
2023 Q3 194 82.4 M $737 M
2023 Q2 180 82.8 M $1.27 B
2023 Q1 182 84.2 M $1.90 B
2022 Q4 165 77.2 M $1.62 B
2022 Q3 182 74.0 M $1.82 B
2022 Q2 180 69.7 M $1.69 B
2022 Q1 180 70.6 M $1.81 B
2021 Q4 190 67.8 M $2.10 B
2021 Q3 160 60.9 M $1.48 B
2021 Q2 147 63.2 M $930 M
2021 Q1 159 65.9 M $1.65 B
2020 Q4 151 53.5 M $1.46 B